A cohort study of cystic fibrosis and malignancy
1993

Cystic Fibrosis and Cancer Risk

Sample size: 412 publication Evidence: moderate

Author Information

Author(s): C.D. Sheldon, M.E. Hodson, L.M. Carpenter, A.J. Swerdlow

Primary Institution: Royal Brompton National Heart and Lung Hospital

Hypothesis

Are patients with cystic fibrosis at greater risk of developing malignancies?

Conclusion

Patients with cystic fibrosis may have an increased risk of certain types of cancer, particularly pancreatic and terminal ileum adenocarcinomas.

Supporting Evidence

  • Four patients developed malignancies during the study period.
  • The observed malignancies were significantly higher than expected based on national rates.
  • Two cases of pancreatic adenocarcinoma were noted, which is rare in young adults.

Takeaway

This study looked at people with cystic fibrosis and found that they might get certain cancers more often than expected.

Methodology

A cohort of 412 cystic fibrosis patients was followed from 1961 to 1989, comparing observed malignancies to expected rates based on national statistics.

Potential Biases

The cohort represents a selected population under regular clinical surveillance, which may not reflect the general risk in all cystic fibrosis patients.

Limitations

The study only included patients from a single hospital and may not represent the general cystic fibrosis population.

Participant Demographics

The cohort included 186 women and 226 men, with the majority aged between 15 and 24 years at first visit.

Statistical Information

P-Value

0.03

Confidence Interval

95% CI 122-1150

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication